Skip to main content
. 2020 Feb 5;13(4):666–673. doi: 10.1093/ckj/sfz182

Table 1.

Characteristics of patients divided according to CV history

Variables Total patients Patients CVD Patients no CVD P-value
Patients, n (M/F) 245 (168/77) 161(112/49) 84(56/28) 0.64
Age (years) 67 ± 14 70 ± 12 62 ± 15 0.0001
Body weight (kg) 66 ± 14 66 ± 14 66 ± 13 0.87
Dialysis vintage (months) 62 ± 64 71 ± 67 45 ± 55 0.002
Serum creatinine (mg/dL) 8.34 ± 2.36 8.25 ± 2.25 8.51 ± 2.54 0.41
Serum calcium (mmol/L) 2.22 ± 0.18 2.21 ± 0.18 2.24 ± 0.18 0.15
Serum phosphate (mmol/L) 1.48 ± 0.54 1.44 ± 0.55 1.55 ± 0.53 0.15
Serum protein (g/dL) 6.54 ± 0.67 6.55 ± 0.68 6.53 ± 0.69 0.81
Serum PTH (pg/mL) 235 ± 197 228 ± 197 248 ± 197 0.44
Serum 1,25(OH)2D (pg/mL) 10.3 ± 10.1 9.5 ± 6.2 11.7 ± 14.5 0.23
Serum 25(OH)D (ng/mL) 13.1 ± 9.8 12.4 ± 10.5 14.3 ± 8.5 0.32
Serum FGF23 (pg/mL) 2158 ± 3543 1874 ± 3181 2654 ± 4078 0.13
Serum CRP (mg/L) 9.1 ± 16.1 11.1 ± 18.8 5.1 ± 7.8 0.001
CV events in a 5-year FU, n (%) 79 (32.2) 73 (45.3) 6 (7.1) 0.0001
CV deaths in a 5-year FU, n (%) 34 (13.9) 34 (21.1) 0 0.0001
All-cause deaths in FU, n (%) 62 (25.3) 49 (30.4) 13 (15.5) 0.011
Diabetes mellitus, n (%) 76 (31) 54 (33.5) 22 (26.2) 0.24
Arterial hypertension, n (%) 235 (95.9) 159 (98.8) 76 (90.5) 0.002

Values are presented as mean ± standard deviation unless stated otherwise.